KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Treasury Shares: 2009-2025

Historic Treasury Shares for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to $4.9 billion.

  • Quest Diagnostics' Treasury Shares rose 3.47% to $4.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.9 billion, marking a year-over-year increase of 3.47%. This contributed to the annual value of $4.9 billion for FY2024, which is 0.64% up from last year.
  • Quest Diagnostics' Treasury Shares amounted to $51.0 million in Q3 2025, which was up 2.00% from $50.0 million recorded in Q2 2025.
  • In the past 5 years, Quest Diagnostics' Treasury Shares registered a high of $51.0 million during Q4 2023, and its lowest value of $1.0 million during Q4 2021.
  • For the 3-year period, Quest Diagnostics' Treasury Shares averaged around $50.6 million, with its median value being $51.0 million (2025).
  • In the last 5 years, Quest Diagnostics' Treasury Shares tumbled by 44.47% in 2021 and then skyrocketed by 49.02% in 2022.
  • Quarterly analysis of 5 years shows Quest Diagnostics' Treasury Shares stood at $3.5 billion in 2021, then spiked by 35.33% to $4.7 billion in 2022, then climbed by 3.27% to $4.8 billion in 2023, then climbed by 0.64% to $4.9 billion in 2024, then increased by 3.47% to $4.9 billion in 2025.
  • Its last three reported values are $4.9 billion in Q3 2025, $4.8 billion for Q2 2025, and $4.8 billion during Q1 2025.